메뉴 바로가기
주메뉴 바로가기
컨텐츠 바로가기
ABOUT US
About us
History
BUSINESS
TB vaccine (QTP101)
COVID-19 vaccine (QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
CONTACT US
KR
EN
SITE MAP
ABOUT US
About us
History
BUSINESS
TB vaccine(QTP101)
COVID-19 vaccine(QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
ABOUT US
About us
History
BUSINESS
TB vaccine (QTP101)
COVID-19 vaccine (QTP104)
CPP Platform
Peptide Nucleic Acid (PNA)
CMO&CDMO
ETC
R&D
Disease Information
Pipeline
Core Technology
Patent
Partners
PR
Notice
Press
PR data
Tuberculosis News
Careers
Quratis
Tel : +82 2 866 0604 Fax : +82 2 867 0125 Email : info@quratis.com
CONTACT US
PR
Notice
Press
PR data
Tuberculosis News
Careers
NOTICE
Finalization of Licensing Agreement with IDRI (Jun 07, 2017)
관리자
|
2017-09-01
Hit
|
3,429
목록